News related to Prohance (Gadoteridol) and/or conditions it is approved for
New diagnostic, treatment approach for aggressive prostate cancer suggested by cholesterol-metabolism study
Source: Cholesterol News From Medical News Today [2014.03.06]
Researchers have discovered a link between prostate cancer aggressiveness and the accumulation of a compound produced when cholesterol is metabolized in cells, findings that could bring new diagnostic and treatment methods.Findings also suggest that a class of drugs previously developed to treat atherosclerosis might be repurposed for treatment of advanced prostate cancer.
Case Made for More Coronary-Spasm Tests at Diagnostic Cath
Source: theheart.org | Medscape Cardiology Headlines [2014.03.03]
Coronary spasm may be a more common cause of angina than often believed in patients without obstructive lesions at angiography; identifying it can facilitate treatment, according to researchers.
New findings could lead to novel diagnostic tests and treatments for male infertility
Source: Endocrinology News From Medical News Today [2014.02.20]
To better understand the causes of male infertility, a team of Bay Area researchers is exploring the factors, both physiological and biochemical, that differentiate fertile sperm from infertile sperm. At the 58th Annual Biophysical Society Meeting, which took place Feb. 15-19, 2014, in San Francisco, Calif.
New study reinforces major advantages of Dako's HER2 IQFISH pharmDx in breast cancer diagnostics
Source: Breast Cancer News From Medical News Today [2014.02.17]
Dako, an Agilent Technologies company and worldwide provider of cancer diagnostics, have announced positive findings in an independent French multicenter study on the performance of Dako's HER2 IQFISH pharmDx(TM).
Schizophrenia enters the molecular diagnostics era
Source: Blood / Hematology News From Medical News Today [2014.02.13]
With a drop of blood and some laboratory analyses, doctors have been able to tell patients whether they suffer from diabetes or some sort of cancer. Measuring changes in the cells or molecules of human tissues or fluids, by detecting so-called biomarkers, has aided the diagnosis of various diseases for some time.
Diagnostic Errors Cause Up To 160,000 Deaths Annually, USA
Source: Litigation / Medical Malpractice News From Medical News Today [2013.04.24]
Misdiagnosing patients or making diagnostic errors is one of the most costly and dangerous mistakes made by doctors in the U.S., resulting in up to 160,000 deaths per year. Johns Hopkins researchers have reviewed over 350,000 malpractice claim payouts in the U.S over the past 25 years.
High-Tech TB Test Fails to Cut Mortality
Source: MedPageToday.com - medical news plus CME for physicians [2014.03.07]
BOSTON (MedPage Today) -- High technology can't compensate for poorly organized healthcare. That appears to be the central lesson of a clinical trial comparing a new automated molecular diagnostic test for tuberculosis to standard sputum microscopy, researchers said here.
Handgrip strength may be linked to a person's ability to fight disease, cancer
Source: Bones / Orthopedics News From Medical News Today [2014.02.28]
New acquaintances are often judged by their handshake. Research has now recognized the simple squeeze as an important diagnostic tool in assessing strength and quality of life among critical care patients.
In screening mammography, novel technique increases detection rate
Source: Radiology / Nuclear Medicine News From Medical News Today [2014.02.06]
Digital mammography screening with new photon-counting technique offers high diagnostic performance, according to a study published online in the journal Radiology.As mammography screening has shifted to digital technology, a range of computed radiography (CR) and direct radiography (DR) systems have emerged.
Test for early diagnosis of lung cancer subject of new Journal of Clinical Oncology paper
Source: Lung Cancer News From Medical News Today [2014.01.15]
GENSIGNIA Ltd, a London-based privately held molecular diagnostics company with laboratory operations in San Diego, CA and Fondazione IRCCS, Istituto Nazionale dei Tumori (INT), Milan, a National Cancer Research Center in Italy, has announced that positive clinical validation results for the microRNA signature classifier (MSC) Lung Cancer assay were published in the Journal of Clinical Oncology...
Diagnosing heart problems earlier by tweaking MRI to track creatine
Source: MRI / PET / Ultrasound News From Medical News Today [2014.01.15]
A new MRI method to map creatine at higher resolutions in the heart may help clinicians and scientists find abnormalities and disorders earlier than traditional diagnostic methods, researchers at the Perelman School of Medicine at the University of Pennsylvania suggest in a new study published online in Nature Medicine.
EAACI calls on MEPs to address allergies diagnosis gap
Source: Allergy News From Medical News Today [2014.01.14]
Last week the European Academy of Allergy and Clinical Immunology (EAACI) conducted three days of diagnostic tests for allergies in the European Parliament. In total 350 people took the opportunity to be examined for sensitivity to the most common allergens and to be given an expert advice, and 47% of them tested positively.
New gene responsible for cleft lip and palate syndrome identified
Source: Cleft Palate News From Medical News Today [2013.12.23]
An international team led by researchers from Karolinska Institutet in Sweden has identified a new gene related to the Van der Woude syndrome, the most common syndrome with cleft lip and palate. The study is published in the scientific periodical American Journal of Human Genetics and can lead the way to improved genetic diagnostic of individuals and families with orofacial clefts.
FDA allows marketing of four "next generation" gene sequencing devices
Source: Cystic Fibrosis News From Medical News Today [2013.11.25]
Today (November 19th, 2013) the U.S. Food and Drug Administration allowed marketing of four diagnostic devices that can be used for high throughput gene sequencing, often referred to as "next generation sequencing" (NGS). These instruments, reagents, and test systems allow labs to sequence a patient's DNA (deoxyribonucleic acid).